Recombinant

Recombinant is a hemostatic agent of different groups, which is produced in Belgium and has the international name of blood clotting factor.

Recombinant is a product of Baxter AG, which is a manufacturer of not only this drug, but also other hemostatic agents. High quality standards are used in the production of Recombinate, which makes it one of the safest and most effective hemostatic agents on the market.

Recombinant is produced in the form of lyophysipat for intravenous injection, which is available in two dosages - 25 and 50 IU. The drug is intended for use in cases where it is necessary to stop bleeding, for example, during injuries, operations, childbirth, bleeding after tooth extraction, etc. Recombinant acts by strengthening the structure of blood vessels and accelerating blood clotting, as a result of which bleeding stops and the body begins to heal the wound.

The use of Recombinate does not require special instructions, however, you should consult your doctor before use. As a rule, the drug is administered intravenously, quickly dissolves in the blood and begins to act within a few minutes. Recombinant is a very popular remedy among doctors and patients because its effectiveness and safety have been proven by numerous studies.